Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Ohta

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Drug Metabolism and Pharmacokinetics|June 28, 2013
The JSSX Annual Meeting: today and the futureShigeru Ohta
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|March 31, 2005
[Study of Parkinson's disease-causing mechanism and development of anti-Parkinson's disease drugs using endogenous substances in brain]Shigeru Ohta
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 2024
[Verification of Pharmaceutical Education System Reform]Shigeru Ohta
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 16, 2018
[Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development]Seigo Sanoh, Shigeru Ohta
Biopharmaceutics & Drug Disposition|October 12, 2013
Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokineticsSeigo Sanoh, Shigeru Ohta
Cardiology in the Young|April 15, 2003
Kawasaki disease complicated by cerebral infarctionKenji Suda, Masahiko Matsumura, Shigeru Ohta
Biological & Pharmaceutical Bulletin|March 5, 2019
Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with in Vitro-in Vivo Extrapolation and Allometric ScalingYoichi Naritomi, Seigo Sanoh, Shigeru Ohta
Drug Metabolism and Pharmacokinetics|May 17, 2006
Drug-metabolizing ability of molybdenum hydroxylasesShigeyuki Kitamura, Kazumi Sugihara, Shigeru Ohta
Biological & Pharmaceutical Bulletin|July 5, 2006
Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivoKatsuhiro Okuda, Yaichiro Kotake, Shigeru Ohta
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compoundsKatsuhiro Okuda, Yaichiro Kotake, Shigeru Ohta
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Drug Metabolism and Pharmacokinetics|June 28, 2013
The JSSX Annual Meeting: today and the futureShigeru Ohta
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|March 31, 2005
[Study of Parkinson's disease-causing mechanism and development of anti-Parkinson's disease drugs using endogenous substances in brain]Shigeru Ohta
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 2024
[Verification of Pharmaceutical Education System Reform]Shigeru Ohta
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 16, 2018
[Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development]Seigo Sanoh, Shigeru Ohta
Biopharmaceutics & Drug Disposition|October 12, 2013
Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokineticsSeigo Sanoh, Shigeru Ohta
Cardiology in the Young|April 15, 2003
Kawasaki disease complicated by cerebral infarctionKenji Suda, Masahiko Matsumura, Shigeru Ohta
Biological & Pharmaceutical Bulletin|March 5, 2019
Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with in Vitro-in Vivo Extrapolation and Allometric ScalingYoichi Naritomi, Seigo Sanoh, Shigeru Ohta
Drug Metabolism and Pharmacokinetics|May 17, 2006
Drug-metabolizing ability of molybdenum hydroxylasesShigeyuki Kitamura, Kazumi Sugihara, Shigeru Ohta
Biological & Pharmaceutical Bulletin|July 5, 2006
Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivoKatsuhiro Okuda, Yaichiro Kotake, Shigeru Ohta
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compoundsKatsuhiro Okuda, Yaichiro Kotake, Shigeru Ohta
Pageof 20